HeraMED’s AI Acceleration Raises Stakes in Digital Women’s Health Race
HeraMED is fast-tracking its AI-driven maternity care technologies, including an early release of its AI Clinician Assistant and predictive models for high-risk pregnancies, aiming to revolutionize digital women’s health globally.
- AI Clinician Assistant initial release advanced to Q4 2025
- Predictive AI maternity care modeling for CALD women underway with Digital Health CRC and RMIT
- Development of AI Virtual Companion for enhanced patient engagement
- Progress on EMR/EHR integration to boost scalability in 2026
- Expansion of connected device compatibility including cellular monitoring
Accelerating AI in Women’s Health
HeraMED Limited (ASX – HMD) has announced a significant acceleration of its artificial intelligence roadmap, aiming to enhance its HeraCARE platform with advanced AI capabilities. The company is pushing forward with a suite of innovations designed to improve maternity care outcomes, streamline clinical workflows, and expand its digital health footprint globally.
Central to this strategy is the early release of the AI Clinician Assistant, now scheduled for the fourth quarter of 2025. This tool will introduce ambient scribing technology to automate clinical documentation during telehealth consultations, reducing administrative burdens and improving accuracy. The assistant is expected to integrate seamlessly with electronic medical records (EMRs), marking a critical step toward workflow automation for clinicians.
Targeting High-Risk Pregnancies with Predictive AI
In collaboration with the Digital Health Cooperative Research Centre and RMIT University, HeraMED has launched a project focused on predictive AI modeling for culturally and linguistically diverse (CALD) women facing high-risk pregnancies. This initiative aims to develop early-warning models that could transform prenatal care by identifying risks sooner and tailoring interventions more effectively. Proof-of-concept models are anticipated in 2026, potentially setting a new standard for personalized maternity care.
Innovative Patient Engagement and Device Integration
Complementing clinical tools, HeraMED is developing an AI Virtual Companion designed to enhance patient engagement through message-based interactions. This scalable solution will support healthcare administrative efficiency and empower women with timely health information. Over the next 18 months, this companion will evolve to become a sophisticated voice-enabled assistant tailored to women’s health needs.
Additionally, HeraMED is expanding its connected device ecosystem beyond Bluetooth to include cellular-enabled devices. This broadens the range of compatible health monitors; such as glucometers and heart rate monitors; facilitating more comprehensive remote monitoring and lifestyle tracking for patients.
Strategic EMR/EHR Integration for Growth
Recognizing the importance of interoperability, HeraMED is advancing foundational work to integrate HeraCARE with leading EMR/EHR systems. This integration is expected to unlock significant growth opportunities by embedding HeraMED’s solutions within major health systems, enhancing adoption and scalability worldwide.
CEO Anoushka Gungadin emphasized the customer-centric approach driving these developments, highlighting the direct input from healthcare partners in shaping the product roadmap. Strategic advisor Vivek Krishnan underscored the company’s commitment to responsible AI and the creation of an integrated digital health ecosystem that could redefine maternity and women’s health care.
Bottom Line?
HeraMED’s accelerated AI roadmap positions it to lead digital maternity care innovation, but execution and adoption will be key to unlocking its full potential.
Questions in the middle?
- How will HeraMED’s AI Clinician Assistant perform in real-world clinical settings upon release?
- What impact will predictive AI models have on outcomes for CALD women with high-risk pregnancies?
- How quickly will HeraMED achieve seamless integration with major EMR/EHR platforms?
